Plain-English translation of NCT07651644 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The TRACE trial is testing an artificial intelligence system designed to help radiologists (imaging doctors) diagnose the stage of stomach cancer more accurately using CT scans. Researchers want to see whether the AI system improves how well doctors can determine how deep the cancer has spread into the stomach wall, which is critical information for planning treatment. The study compares diagnoses made with the AI system's assistance to diagnoses made without it.
Determining the exact stage of stomach cancer before surgery is very important for treatment planning, but doctors' diagnoses sometimes vary, and imaging alone can be tricky to interpret. This trial aims to see whether this AI system can reduce those variations and help doctors make more accurate, consistent diagnoses.
You likely qualify if…
You likely don't qualify if…
If you're a patient, your role is fairly simple: your existing CT scans and pathology results will be reviewed by radiologists in two separate reading sessions about one month apart. If you're a radiologist participating, you will review the same set of CT scans twice — once using the AI system to assist your diagnosis, and once reading them on your own — with a one-month break between readings to avoid remembering your first interpretation. The study tracks whether the AI assistance changes the accuracy of cancer staging and how confident the doctors feel about their diagnoses.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China